News | March 29, 2022
Alembic Pharma acquires 100% stake in Aleor Dermaceuticals
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
Brinton Pharmaceuticals enters exclusive sales and distribution rights of Scholl foot care products including Krack cream
The facility will cater to the storage, handling and transportation of pharma, dairy products seafood among others
Key takeaways of Q3FY22 quarter & conference call highlights
Platina 250, 300 & 350 Lamitubes have been recognized by the Association of Plastic Recyclers (APR), USA as meeting or exceeding the strict APR HDPE critical guidance criteria on recyclability
This test is inexpensive and results are available immediately as compared to the genetic test
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
Acne affects up to 50 million Americans annually. The last FDA approval of an acne drug with a new MOA occurred nearly 40 years ago
Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older
Subscribe To Our Newsletter & Stay Updated
